Solution
Industries
Resources
About
Beacon Search

BHARAT BIOTECH

Company Snapshot

Founded: 1996
Entity Type: Private
Region: India
Headquarter: India
Key Geographics: Asia-Pacific
Corporate Address: Genome Valley Shameerpet Hyderabad – 500078 Telangana  India Tel. +91-40-2778-4084 www.bharatbiotech.com

Company Overview

Bharat Biotech, founded in 1996 and based in Hyderabad, India, is a biotechnology company that offers vaccines and biotherapeutics. With over 50 technology-driven patents, Bharat Biotech is a multidimensional biotechnology company involved in quality product-oriented R&D. The company has various private/public partnerships for vaccine development. Bharat Biotech is working with the Department of Science and Technology and the Indian Institute of Science, Bangalore, on the development of a third-generation hepatitis B vaccine. The company’s product pipeline includes vaccines for HPV, chikungunya, malaria PvR II, and methicillin-resistant Staphylococcus aureus. The company’s vaccine ROTAVAC was found to be safe and effective in preventing rotavirus diarrhea and reducing hospitalizations due to diarrhea.

BHARAT BIOTECH In Reports

Global Markets for Vaccine Technologies

BCC Research Market Analyst says global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a CAGR of 7.8% from 2023 to 2028.

Nasal Vaccines: Global Markets and Pipeline Analysis

Global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a CAGR of 8.2% for 2022-27.

Pediatric Vaccines: Global Markets

BCC Research Market Report for Pediatric Vaccines. Global Pediatric Vaccines market trends, with market revenue and CAGRs through 2027.

View All Reports

BHARAT BIOTECH In News

GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development - GSK

GSK - Jun 12, 2025

GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028 - Fierce Pharma

Fierce Pharma - Jun 25, 2025

Bharat Biotech acquires licence to develop GSK's Shigella vaccine - Pharmaceutical Technology

Pharmaceutical Technology - Jun 13, 2025

GSK offloads shigella vaccine to Bharat ahead of phase 3, vows to support fundraising - Fierce Biotech

Fierce Biotech - Jun 12, 2025

Read All News

Company's Business Segments

  • Vaccines and Bio-therapeutic : The company offers specialized product-oriented research and development leading to the manufacturing of vaccines and biotherapeutics.

Applications/End User Industries

  • Healthcare
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment